tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isonicotinate

Catalog No. :
ACMKVE843
CAS No. :
1310385-01-3
Molecular Formula :
C16H24BNO4
Molecular Weight :
305.18

IUPAC Name:tert-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isonicotinate

tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isonicotinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$504.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isonicotinate
IUPAC Nametert-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isonicotinate
MDL No.MFCD09839168
Molecular FormulaC16H24BNO4
Molecular Weight305.18
SMILESO=C(OC(C)(C)C)C1=CC=NC(B2OC(C)(C)C(C)(C)O2)=C1
InChI KeyHWNNRLTZVPCYQU-UHFFFAOYSA-N
Synonymtert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isonicotinate;4-(TERT-BUTOXYCARBONYL)PYRIDINE-2-BORONIC ACID PINACOL ESTER
CAS No.1310385-01-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMKVE843 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZKBS789 route compound structure diagram
    ACZKBS789887579-30-8 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACMKVE843 route product structure diagram
    ACMKVE8431310385-01-3
Inquiry

2. ACMKVE843 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5 In Stock
  4. Then
  5. ACMKVE843 route product structure diagram
    ACMKVE8431310385-01-3
Inquiry

Comments (0)